• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    MeiraGTx Holdings plc - Ordinary Shares (NQ:MGTX)

    9.210 -0.560 (-5.73%)
    Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 596,805
    Open 9.700
    Bid (Size) 9.000 (300)
    Ask (Size) 10.23 (900)
    Prev. Close 9.770
    Today's Range 9.080 - 9.720
    52wk Range 6.620 - 15.35
    Shares Outstanding 80,479,684
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch. ↗
    One of J&J's investments stands head-and-shoulders above the rest. 
    Via The Motley Fool

    Performance

    52-Week Range 40.0% below 52-week high
    9.210
    6.6252W Low 15.3552W High
    1 Week 10.0% below 1-week high
    9.081W Low 10.231W High

    MeiraGTx Holdings plc - Ordinary Shares (MGTX) traded between $6.62 and $15.35 over the past 52 weeks and last traded at $9.21, 40.0% below its 52-week high. Over the past week it ranged between $9.08 and $10.23.

    Past 12 Months
    -2.5%
    -21.6%
    -21.8%
    -0.2%
    +17.9%
    +5.3%
    1W -$0.24
    1M -$2.54
    3M -$2.56
    6M -$0.02
    YTD +$1.40
    1Y +$0.46

    MGTX was +5.3% over the past year, -0.2% over six months, +17.9% year to date, -2.5% in the last week.

    12 Months vs Market
    MGTX
    +5.3%
    DIA
    +11.6%
    SPY
    +13.1%
    QQQ
    +15.4%
    IWM
    +11.9%

    Over the past 12 months MGTX returned +5.3% versus DIA (Dow) +11.6%, SPY (S&P 500) +13.1%, QQQ (Nasdaq 100) +15.4% and IWM (Russell 2000) +11.9%.

    Volume & Liquidity 0.75× 3-mo avg
    Today 596,805 3-mo avg 794.4K
    1W
    643.9K
    1M
    987.0K
    3M
    794.4K
    6M
    845.0K
    YTD
    755.0K
    1Y
    715.5K

    MGTX most recently traded 596,805 shares against a 3-month average daily volume of 794.4K.

    More News

    Read More
    MeiraGTx (NASDAQ:MGTX) Clears Minervini Trend Template and High-Growth Momentum Screen ↗
    Via Chartmill
    News headline image
    MeiraGTx Reports Second Quarter 2026 Financial and Operational Results
    From MeiraGTx
    Via GlobeNewswire
    MeiraGTx Holdings (NASDAQ:MGTX) Passes Minervini Trend Template and High Growth Momentum Screen ↗
    Via Chartmill
    MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle? ↗
    Via Stocktwits
    News headline image
    MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Reports First Quarter 2026 Financial and Operational Results
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Announces Pricing of $100 Million Offering of Ordinary Shares
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results
    From MeiraGTx
    Via GlobeNewswire
    Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
    Via Investor Brand Network
    Topics Intellectual Property
    News headline image
    The Biotech Tug-of-War: Is Kiora Pharmaceuticals Positioned to Ride the 2025 Commodity Wave?
    Via MarketMinute
    Topics Derivatives Economy Intellectual Property
    News headline image
    Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
    From BioMedWire
    Via GlobeNewswire
    News headline image
    MeiraGTx Reports Third Quarter 2025 Financial and Operational Results
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    Eli Lilly Expands Genetic Eye-Disease Focused Pipeline With MeiraGTx Gene Therapy Collaboration ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress
    From MeiraGTx
    Via GlobeNewswire
    News headline image
    MeiraGTx Sales Jump 1,133 Percent ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is MeiraGTx Holdings plc - Ordinary Shares publicly traded?
    Yes, MeiraGTx Holdings plc - Ordinary Shares is publicly traded.
    What exchange does MeiraGTx Holdings plc - Ordinary Shares trade on?
    MeiraGTx Holdings plc - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for MeiraGTx Holdings plc - Ordinary Shares?
    The ticker symbol for MeiraGTx Holdings plc - Ordinary Shares is MGTX on the Nasdaq Stock Market
    What is the current price of MeiraGTx Holdings plc - Ordinary Shares?
    The current price of MeiraGTx Holdings plc - Ordinary Shares is 9.210
    When was MeiraGTx Holdings plc - Ordinary Shares last traded?
    The last trade of MeiraGTx Holdings plc - Ordinary Shares was at 10/23/26 04:00 PM ET
    What is the market capitalization of MeiraGTx Holdings plc - Ordinary Shares?
    The market capitalization of MeiraGTx Holdings plc - Ordinary Shares is 741.22M
    How many shares of MeiraGTx Holdings plc - Ordinary Shares are outstanding?
    MeiraGTx Holdings plc - Ordinary Shares has 741M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.